Back to Search
Start Over
Prediction of the Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer Patients With MRI-Radiomics: A Systematic Review and Meta-analysis.
- Source :
- Current Problems in Cancer; Oct2022, Vol. 46 Issue 5, pN.PAG-N.PAG, 1p
- Publication Year :
- 2022
-
Abstract
- We performed a systematic review and a meta-analysis of studies using MRI-radiomics for predicting the pathological complete response in breast cancer patients undergoing neoadjuvant therapy , and we evaluated their methodological quality using the radiomics-quality-score (RQS). Random effects meta-analysis was performed pooling area under the receiver operating characteristics curves. Publication-bias was assessed using the Egger's test and visually inspecting the funnel plot. Forty-three studies were included in the qualitative review and 34 in the meta-analysis. Summary area under the receiver operating characteristics curve was 0,78 (95%CI:0,74-0,81). Heterogeneity according to the I<superscript>2</superscript> statistic was substantial (71%) and there was no evidence of publication bias (P -value = 0,2). The average RQS was 12,7 (range:−1-26), with an intra-class correlation coefficient of 0.93 (95%CI:0.61-0.97). Year of publication, field intensity and synthetic RQS score do not appear to be moderators of the effect (P -value = 0.36, P -value = 0.28 and P -value = 0.92, respectively). MRI-radiomics may predict response to neoadjuvant therapy in breast cancer patients but the heterogeneity of the current studies is still substantial. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01470272
- Volume :
- 46
- Issue :
- 5
- Database :
- Supplemental Index
- Journal :
- Current Problems in Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 159328826
- Full Text :
- https://doi.org/10.1016/j.currproblcancer.2022.100883